Compare Cytokinetics Inc (CYTK) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Unilever plc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.78B), while Unilever plc trades at $62.32 (market cap $134.76B). The key difference: Unilever plc is far larger — about 12.5× Cytokinetics Inc's market cap, and Unilever plc pays a 3.63% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | UL | |
|---|---|---|
Market Cap | $10.78B | $134.76B |
Sector | Technology | Consumer Staples |
52-Week High | $87.26 | $74.59 |
52-Week Low | $33.23 | $55.05 |
Enterprise Value | $10.88B | $160.58B |
Dividend Yield | — | 3.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
Unilever (UL) trades at $62.96, down 1.1% over 24 hours, with technical indicators showing a bullish trend and strong support at $62. The company reported $50.5B revenue in 2025 with a net income margin of 18.75%, though recent quarters saw earnings misses. Positive sentiment is driven by a potential merger with McCormick and strong Q2 2026 volume growth, while analyst consensus is mixed with 24% buy ratings.
The outlook is cautiously optimistic due to merger synergies and margin expansion potential, but risks include integration challenges and competitive pressures. Cash flow volatility and debt levels warrant monitoring. The stock presents a value opportunity if execution improves, but near-term volatility may persist amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
